Live feed
Filing
SC 13G
SC 13G0000902664-19-001327·ADIAL PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
ADIAL PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00688A106
Event date: 2019-02-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 816,051
- Percent of class
- 8.4100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-19-001327
- Form type
- SC 13G
- Filer
- ADIAL PHARMACEUTICALS, INC.
- CIK
- CIK 1513525
- Filed
- Mar 01, 2019
- Reporting period
- Feb 21, 2019
- Description
- Schedule 13G beneficial ownership